FIELD: medicine.
SUBSTANCE: red blood cells of a patient suffering from locally advanced cervical cancer (Stages Ib-IIa) according to the FIGO system are exposed to a single femtosecond pulse laser light emission in vitro in a test tube. An emission wavelength is 1.55 mcm with a dose of 0.10 J/cm2.
EFFECT: method enables reducing stiffness of red blood cell membranes without oxidative stress in patients suffering from cervical cancer.
2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR UTERINE CANCER | 2012 |
|
RU2488823C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF CERVICAL INTRAEPITHELIAL NEOPLASIA OF GRADE III AND MICROINVASIVE CERVICAL CANCER ASSOCIATED WITH HUMAN PAPILLOMA VIRUS | 2019 |
|
RU2735660C1 |
| METHOD FOR PREDICTION OF RECURRENCE-FREE SIRVIVAL IN CERVICAL CANCER BY BLOOD PLASMA CATALASE ACTIVITY TEST | 2012 |
|
RU2483308C1 |
| CERVICAL CANCER STAGING METHOD | 2016 |
|
RU2645111C2 |
| METHOD FOR PREDICTION OF RECURRENCE-FREE SURVIVAL IN CERVICAL CANCER | 2012 |
|
RU2487359C1 |
| METHOD OF UPDATING STAGE OF ADVANCED CERVICAL CANCER | 2015 |
|
RU2582979C1 |
| METHOD FOR PREDICTION OF RECURRENCE-FREE SIRVIVAL IN CERVICAL CANCER BY CANCER TISSUE GLUTATHIONE REDUCTASE ACTIVITY TEST | 2012 |
|
RU2483304C1 |
| METHOD FOR DIAGNOSIS OF METASTASES TO LYMPH NODES OF SMALL PELVIS IN PATIENTS WITH RESECTABLE CERVICAL CANCER | 2020 |
|
RU2750769C2 |
| METHOD OF PREDICTION OF PROBABILITY OF CERVICAL CANCER DETECTION BASED ON ROUTINE BLOOD PARAMETERS | 2023 |
|
RU2802395C2 |
| METHOD OF TREATING BACKGROUND AND PRECANCEROUS CERVICAL DISEASES | 2023 |
|
RU2813949C1 |
